L

Ligand Pharmaceuticals
D

LGND

114.350
USD
-0.45
(-0.39%)
مفتوح الان
حجم التداول
862
الربح لكل سهم
5
العائد الربحي
-
P/E
46
حجم السوق
2,160,685,903
أصول ذات صلة
    A
    ACAD
    0.070
    (0.41%)
    16.950 USD
    A
    AGIO
    -0.060
    (-0.17%)
    35.330 USD
    ALNY
    ALNY
    -7.145
    (-2.91%)
    238.360 USD
    B
    BLUE
    -0.82000
    (-9.66%)
    7.67000 USD
    I
    ICPT
    0.000000
    (0.00%)
    0.000000 USD
    I
    INCY
    0.100
    (0.15%)
    69.010 USD
    J
    JAZZ
    -0.030
    (-0.02%)
    122.940 USD
    N
    NBIX
    -0.650
    (-0.48%)
    134.810 USD
    VRTX
    VRTX
    1.64
    (0.41%)
    398.36 USD
    المزيد
الأخبار المقالات

العنوان: Ligand Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.